New Delhi, Drug firm Venus Remedies on Monday said it has received good manufacturing practices (GMF) certification from the Saudi drug regulator for its production facilities at Baddi, Himachal Pradesh. The Saudi Food and Drug Authority (SFDA) granted the certification which includes first-time approval for pre-filled enoxaparin syringes and general injection facilities, the company said in a regulatory filing.

The authority also renewed approval for Cephalosporin and Carbapenem antibiotics and liquid and lyophilised oncology drugs, after an extensive review and audit of the company’s facilities, it added.

Shares of the company were trading 1.99 per cent up at Rs 163.90 apiece on BSE.